Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

SNDX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.10%

Insider Buying (Last 12 Months): $25,037.50

Insider Selling (Last 12 Months): $0.00

Syndax Pharmaceuticals Insider Trading History Chart

Syndax Pharmaceuticals Share Price & Price History

^$21.35

▲ +1.66 (8.43%)

As of 11/6/2024 05:00 PM ET

Days: 30 | 90 | 365

⭕ [URGENT] Buy Alert just triggered

From Behind the Markets | Ad

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>

Syndax Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/14/2024	Keith A Goldan	CFO	Buy	1,250	$20.03	$25,037.50	52,623
8/9/2023	Briggs Morrison	Director	Sell	52,855	$18.27	$965,660.85	17,836
8/2/2023	William Meury	Director	Sell	83,000	$20.46	$1,698,180.00	48,000
7/10/2023	Briggs Morrison	Director	Sell	52,855	$20.40	$1,078,242.00	17,836
6/13/2023	Keith A Goldan	CFO	Sell	577	$22.31	$12,872.87	2,628
6/9/2023	Briggs Morrison	Director	Sell	52,855	$21.18	$1,119,468.90	17,836
5/9/2023	Briggs Morrison	Director	Sell	52,855	$21.41	$1,131,625.55	17,836
4/10/2023	Briggs Morrison	Director	Sell	52,855	$19.53	$1,032,258.15	17,836
3/13/2023	Briggs Morrison	Insider	Sell	52,854	$22.53	$1,190,800.62	17,836
2/15/2023	Peter Ordentlich	insider	Sell	25,000	$25.84	$646,000.00
2/6/2023	Briggs Morrison	Insider	Sell	52,854	$26.83	$1,418,072.82	17,836
2/6/2023	Michael A. Metzger	CEO	Sell	5,959	$27.64	$164,706.76	17,659
1/12/2023	Pierre Legault	Director	Sell	24,000	$26.74	$641,760.00	32,000
12/1/2022	Peter Ordentlich	Insider	Sell	7,800	$25.01	$195,078.00	265
10/6/2022	Keith Katkin	Director	Sell	29,899	$25.90	$774,384.10	32,000
10/6/2022	Michael A. Metzger	CEO	Sell	16,231	$25.29	$410,481.99	17,659
10/4/2022	Michael A. Metzger	CEO	Sell	1,280	$25.02	$32,025.60	17,659
10/3/2022	Keith Katkin	Director	Sell	180	$25.00	$4,500.00	32,000
9/30/2022	Keith Katkin	Director	Sell	3,561	$25.07	$89,274.27	32,000
9/30/2022	Michael A. Metzger	CEO	Sell	29,606	$25.02	$740,742.12	17,659
9/20/2022	Briggs Morrison	Insider	Sell	59,649	$23.25	$1,386,839.25	17,836
9/16/2022	Dennis Podlesak	Director	Sell	11,975	$23.43	$280,574.25	75,763
9/15/2022	Briggs Morrison	Insider	Sell	66,775	$24.20	$1,615,955.00	17,836
8/24/2022	Peter Ordentlich	Insider	Sell	25,000	$25.04	$626,000.00	265
7/25/2022	Michael A. Metzger	CEO	Sell	31,602	$21.06	$665,538.12	17,659
7/7/2022	Michael A. Metzger	CEO	Sell	100	$21.00	$2,100.00	17,659
7/1/2022	Briggs Morrison	Insider	Sell	62,292	$19.00	$1,183,548.00	17,836
4/4/2022	Briggs Morrison	Insider	Sell	3,128	$18.29	$57,211.12	17,836
4/1/2022	Briggs Morrison	Insider	Sell	101,045	$17.45	$1,763,235.25	17,836
2/1/2022	Alexander Nolte	CAO	Sell	968	$16.65	$16,117.20
2/1/2022	Peter Ordentlich	Insider	Sell	1,412	$16.65	$23,509.80
12/22/2021	Pierre Legault	Director	Sell	24,000	$22.01	$528,240.00
12/20/2021	Michael A. Metzger	COO	Sell	61,000	$20.29	$1,237,690.00
12/20/2021	Pierre Legault	Director	Sell	20,000	$21.01	$420,200.00
12/17/2021	Briggs Morrison	CEO	Sell	35,156	$20.00	$703,120.00
12/17/2021	Michael A. Metzger	COO	Sell	1,676	$19.02	$31,877.52
12/13/2021	Michael A. Metzger	COO	Sell	36,609	$19.05	$697,401.45
11/18/2021	Fabrice Egros	Director	Sell	14,030	$18.03	$252,960.90

NASDAQ traded stock with a BIG short position.

From Huge Alerts | Ad

Small cap NASDAQ firm is an innovative leader in non-opioid pain therapeutics. The company’s offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth!

See how this NASDAQ Bio-tech is offering viable solutions

SEC Filings (Institutional Ownership Changes) for Syndax Pharmaceuticals (NASDAQ:SNDX)

Institutional Buying and Selling by Quarter

Syndax Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/6/2024	Simplify Asset Management Inc.	122,185	$2.35M	0.1%	+62.5%	0.144%
11/2/2024	Mesirow Financial Investment Management Inc.	10,126	$0.20M	0.0%	-18.0%	0.012%
11/1/2024	Atria Investments Inc	18,928	$0.36M	0.0%	N/A	0.022%
10/25/2024	China Universal Asset Management Co. Ltd.	16,367	$0.32M	0.0%	+63.9%	0.019%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	3,078	$58K	0.0%	+21.3%	0.004%
10/23/2024	Values First Advisors Inc.	1,546	$30K	0.0%	N/A	0.002%
10/23/2024	Assenagon Asset Management S.A.	466,028	$8.97M	0.0%	+8.6%	0.548%
10/11/2024	Creative Planning	16,498	$0.32M	0.0%	-10.5%	0.019%
10/10/2024	Inspire Investing LLC	21,308	$0.41M	0.0%	+23.2%	0.025%
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	228,625	$4.69M	0.0%	-70.7%	0.269%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	11,404	$0.23M	0.0%	N/A	0.013%
8/20/2024	Nantahala Capital Management LLC	453,232	$9.31M	0.5%	-2.6%	0.533%
8/16/2024	Quarry LP	6,125	$0.13M	0.0%	+75.0%	0.007%
8/16/2024	Northwestern Mutual Wealth Management Co.	1,300	$27K	0.0%	N/A	0.002%
8/16/2024	Creative Planning	18,428	$0.38M	0.0%	+27.4%	0.022%
8/16/2024	Clearline Capital LP	42,195	$0.87M	0.0%	N/A	0.050%
8/16/2024	Algert Global LLC	432,128	$8.87M	0.3%	+1.5%	0.508%
8/15/2024	The Manufacturers Life Insurance Company	48,668	$1M	0.0%	+16.1%	0.057%
8/15/2024	Millennium Management LLC	1,065,508	$21.88M	0.0%	+56.3%	1.252%
8/15/2024	AQR Capital Management LLC	27,273	$0.56M	0.0%	-48.8%	0.032%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	11,404	$0.23M	0.0%	N/A	0.013%
8/14/2024	Point72 DIFC Ltd	10,737	$0.22M	0.0%	N/A	0.013%
8/14/2024	Marshall Wace LLP	1,830,427	$37.58M	0.1%	-9.9%	2.151%
8/14/2024	Avoro Capital Advisors LLC	3,888,437	$79.83M	1.1%	-7.9%	4.569%
8/14/2024	ProShare Advisors LLC	31,600	$0.65M	0.0%	+57.1%	0.037%
8/14/2024	Profund Advisors LLC	33,231	$0.68M	0.0%	-42.9%	0.039%
8/13/2024	Ensign Peak Advisors Inc	518,885	$10.65M	0.0%	+0.8%	0.610%
8/13/2024	Sei Investments Co.	45,928	$0.94M	0.0%	+13.5%	0.054%
8/13/2024	Public Employees Retirement Association of Colorado	13,746	$0.28M	0.0%	-15.3%	0.016%
8/12/2024	Inspire Investing LLC	17,290	$0.36M	0.0%	+15.0%	0.020%
8/12/2024	Seven Eight Capital LP	75,971	$1.56M	0.2%	+688.2%	0.089%
8/12/2024	Hsbc Holdings PLC	43,597	$0.88M	0.0%	+10.1%	0.051%
8/12/2024	E Fund Management Co. Ltd.	10,806	$0.22M	0.0%	-38.7%	0.013%
8/10/2024	Sofinnova Investments Inc.	2,153,669	$44.22M	2.3%	+33.9%	2.531%
8/9/2024	Renaissance Technologies LLC	214,300	$4.40M	0.0%	+170.9%	0.252%
8/9/2024	Dimensional Fund Advisors LP	70,181	$1.44M	0.0%	-35.4%	0.082%
8/8/2024	Federated Hermes Inc.	656,250	$13.47M	0.0%	+21.8%	0.772%
8/8/2024	First Turn Management LLC	640,389	$13.15M	2.1%	N/A	0.754%
8/8/2024	Nicholas Investment Partners LP	62,366	$1.28M	0.1%	N/A	0.073%
8/8/2024	American Century Companies Inc.	9,803	$0.20M	0.0%	N/A	0.012%
8/8/2024	State of New Jersey Common Pension Fund D	94,313	$1.94M	0.0%	-17.5%	0.111%
8/6/2024	Quest Partners LLC	13,635	$0.28M	0.0%	+138.9%	0.016%
8/6/2024	Candriam S.C.A.	970,106	$19.92M	0.1%	-7.2%	1.141%
8/1/2024	Rhumbline Advisers	119,285	$2.45M	0.0%	+9.4%	0.140%
7/31/2024	nVerses Capital LLC	1,600	$33K	0.0%	N/A	0.002%
7/29/2024	Peregrine Capital Management LLC	198,659	$4.08M	0.1%	+1.3%	0.234%
7/29/2024	Principal Financial Group Inc.	14,167	$0.29M	0.0%	-24.8%	0.017%
7/29/2024	Panagora Asset Management Inc.	82,849	$1.70M	0.0%	-65.0%	0.097%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	12,235	$0.25M	0.0%	-33.1%	0.014%
7/26/2024	Bank of New York Mellon Corp	291,826	$5.99M	0.0%	+18.9%	0.343%
7/18/2024	Assenagon Asset Management S.A.	428,949	$8.81M	0.0%	+54.3%	0.505%
7/12/2024	SG Americas Securities LLC	31,051	$0.64M	0.0%	N/A	0.037%
7/5/2024	DNB Asset Management AS	13,172	$0.27M	0.0%	+40.6%	0.015%
5/17/2024	Zimmer Partners LP	155,000	$3.69M	0.1%	-43.7%	0.182%
5/16/2024	California State Teachers Retirement System	76,557	$1.82M	0.0%	+1.5%	0.090%
5/16/2024	Iron Triangle Partners LP	973,057	$23.16M	2.4%	N/A	1.145%
5/16/2024	Janus Henderson Group PLC	48,948	$1.16M	0.0%	+85.1%	0.058%
5/16/2024	Kingdon Capital Management L.L.C.	894,993	$21.30M	2.3%	+19.9%	1.053%
5/15/2024	Public Employees Retirement Association of Colorado	16,224	$0.39M	0.0%	-26.0%	0.019%
5/15/2024	Price T Rowe Associates Inc. MD	44,510	$1.06M	0.0%	+69.5%	0.052%
5/15/2024	PEAK6 Investments LLC	23,041	$0.55M	0.0%	+31.4%	0.027%
5/14/2024	EntryPoint Capital LLC	8,636	$0.21M	0.2%	+487.1%	0.010%
5/14/2024	StemPoint Capital LP	1,100,988	$26.20M	6.9%	+0.6%	1.295%
5/14/2024	Propel Bio Management LLC	83,259	$1.98M	1.1%	N/A	0.098%
5/14/2024	CANADA LIFE ASSURANCE Co	7,182	$0.17M	0.0%	+28.4%	0.008%
5/14/2024	American International Group Inc.	38,832	$0.92M	0.0%	+16.9%	0.046%
5/13/2024	Seven Eight Capital LP	9,639	$0.23M	0.0%	N/A	0.011%
5/13/2024	Ameritas Investment Partners Inc.	7,858	$0.19M	0.0%	+20.0%	0.009%
5/10/2024	Vanguard Group Inc.	4,926,984	$117.26M	0.0%	+13.6%	5.799%
5/9/2024	State Board of Administration of Florida Retirement System	13,218	$0.32M	0.0%	-30.3%	0.016%
5/8/2024	Entropy Technologies LP	16,590	$0.40M	0.0%	-45.7%	0.020%
5/8/2024	ProShare Advisors LLC	20,112	$0.48M	0.0%	+29.6%	0.024%
5/8/2024	Russell Investments Group Ltd.	10,412	$0.25M	0.0%	-39.1%	0.012%
5/8/2024	Inspire Investing LLC	15,032	$0.36M	0.0%	-15.5%	0.018%
5/7/2024	Sei Investments Co.	40,463	$0.96M	0.0%	+2.5%	0.048%
5/7/2024	Susquehanna Fundamental Investments LLC	109,827	$2.61M	0.1%	N/A	0.129%
5/7/2024	Swiss National Bank	150,600	$3.58M	0.0%	+5.8%	0.177%
5/7/2024	Nvwm LLC	42,962	$1.02M	0.3%	N/A	0.051%
5/2/2024	Jennison Associates LLC	50,170	$1.19M	0.0%	-1.2%	0.059%
5/1/2024	BNP Paribas Financial Markets	45,602	$1.09M	0.0%	-72.0%	0.054%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	40,268	$0.89M	0.0%	-14.1%	0.047%
4/29/2024	Principal Financial Group Inc.	18,829	$0.45M	0.0%	-65.9%	0.022%
4/29/2024	China Universal Asset Management Co. Ltd.	16,338	$0.39M	0.0%	+102.8%	0.019%
4/26/2024	Mesirow Financial Investment Management Inc.	12,318	$0.29M	0.0%	-23.1%	0.014%
4/24/2024	Assenagon Asset Management S.A.	277,928	$6.62M	0.0%	-32.5%	0.327%
4/19/2024	Mesirow Financial Investment Management Inc.	12,318	$0.29M	1.5%	-23.1%	0.014%
4/18/2024	Diversified Trust Co	15,523	$0.37M	0.0%	N/A	0.018%
3/18/2024	Kingdon Capital Management L.L.C.	746,293	$16.13M	2.0%	N/A	0.878%
3/11/2024	Vanguard Group Inc.	4,335,353	$93.69M	0.0%	+19.9%	5.103%
3/5/2024	Wellington Management Group LLP	7,585,221	$163.92M	0.0%	-0.7%	8.928%
3/1/2024	Goldman Sachs Group Inc.	1,250,948	$27.03M	0.0%	-1.3%	1.472%
2/26/2024	Virtu Financial LLC	11,948	$0.26M	0.0%	N/A	0.014%
2/15/2024	PFM Health Sciences LP	595,523	$12.87M	0.8%	-78.1%	0.702%
2/15/2024	Parkman Healthcare Partners LLC	738,589	$15.96M	2.3%	+247.7%	0.871%
2/15/2024	BVF Inc. IL	1,875,000	$40.52M	1.0%	N/A	2.211%
2/14/2024	Point72 Asset Management L.P.	2,834,499	$61.25M	0.1%	+35.3%	3.342%
2/14/2024	Avidity Partners Management LP	3,950,000	$85.36M	3.1%	+40.0%	4.657%
2/14/2024	Avoro Capital Advisors LLC	4,222,222	$91.24M	1.3%	+65.2%	4.978%
2/14/2024	Kynam Capital Management LP	5,660,000	$122.31M	13.6%	+41.5%	6.674%
2/14/2024	Lighthouse Investment Partners LLC	52,199	$1.13M	0.1%	N/A	0.062%

Data available starting January 2016

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are revumenib, a potent, selective, small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged, acute leukemias, and solid tumor; and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD) and idiopathic pulmonary fibrosis (IPF). The company is also developing Entinostat. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $21.35

$20.34

$22.26

50 Day Range

MA: $19.05

$17.93

$20.66

52 Week Range

Now: $21.35

$13.14

$25.34

Volume

3,839,703 shs

Average Volume

1,062,119 shs

Market Capitalization

$1.82 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Who are the company insiders with the largest holdings of Syndax Pharmaceuticals?: Syndax Pharmaceuticals' top insider investors include:
Keith A Goldan (CFO)
William Meury (Director)
Pierre Legault (Director)
Briggs Morrison (Director)
Briggs Morrison (Insider)
Michael A Metzger (CEO)
Peter Ordentlich (Insider)
Learn More about top insider investors at Syndax Pharmaceuticals.
Who are the major institutional investors of Syndax Pharmaceuticals?: Syndax Pharmaceuticals' top institutional investors include:
Assenagon Asset Management S.A. — 0.55%
Simplify Asset Management Inc. — 0.14%
Inspire Investing LLC — 0.03%
Atria Investments Inc — 0.02%
Creative Planning — 0.02%
China Universal Asset Management Co. Ltd. — 0.02%
Learn More about top institutional investors of Syndax Pharmaceuticals stock.
Which major investors are selling Syndax Pharmaceuticals stock?: During the previous quarter, SNDX stock was sold by these institutional investors:
Mesirow Financial Investment Management Inc.
Creative Planning
Which major investors are buying Syndax Pharmaceuticals stock?: During the last quarter, SNDX stock was acquired by institutional investors including:
Simplify Asset Management Inc.
Assenagon Asset Management S.A.
Atria Investments Inc
China Universal Asset Management Co. Ltd.
Inspire Investing LLC
Values First Advisors Inc.
Mirae Asset Global Investments Co. Ltd.